FBC
LLY icon

Fairfield, Bush & Co’s Eli Lilly LLY Stock Holding History

Fairfield, Bush & Co’s Portfolio LLY Stock Details LLY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-400
Closed -$129K – 123
2022
Q3 		$129K Buy
+400
New +$127K 0.09% 115

Other funds holding LLY

Lilly Endowment
Lilly Endowment Indiananapolis, Indiana $108B AUM 53.87% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
PNC Financial Services Group
PNC Financial Services Group Pittsburgh, Pennsylvania $202B AUM 37.79% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Fairfield, Bush & Co's LLY Position: Q2 2026 in Review

Fairfield, Bush & Co increased its Eli Lilly (LLY) stake by 1.1% in Q2 2026, buying an estimated $32.7K and bringing the position to 2,869 shares worth $3.44M. The position accounts for 1.69% of the portfolio, ranked #15.

Fairfield, Bush & Co first reported a position in LLY in Q2 2013 and has held it in 51 quarters since. The position peaked at $12.4M in Q2 2023. 4,630 funds tracked by Wall St. Rank hold LLY as of Q2 2026.

  • Fairfield, Bush & Co held 2,869 shares of Eli Lilly worth $3.44M as of Q2 2026.
  • Fairfield, Bush & Co bought 32 Eli Lilly shares in Q2 2026, an estimated $32.7K.
  • Eli Lilly made up 1.69% of Fairfield, Bush & Co's portfolio in Q2 2026, its #15 holding.
  • Fairfield, Bush & Co first reported a position in Eli Lilly in Q2 2013 and has held it in 51 quarters since.
  • Fairfield, Bush & Co's Eli Lilly position peaked at $12.4M in Q2 2023.
  • 4,630 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2026.

Based on Fairfield, Bush & Co's 13F filing for Q2 2026, filed 13 Aug 2026.